OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
I‐Hsin Huang, Yi‐Teng Hung, Po‐Chien Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 125
I‐Hsin Huang, Yi‐Teng Hung, Po‐Chien Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 125
Showing 1-25 of 125 citing articles:
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 175
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 175
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 56
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 56
JAK-STAT pathway inhibitors in dermatology
Hélio Amante Miot, Paulo Ricardo Criado, Caio César Silva de Castro, et al.
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 5, pp. 656-677
Open Access | Times Cited: 41
Hélio Amante Miot, Paulo Ricardo Criado, Caio César Silva de Castro, et al.
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 5, pp. 656-677
Open Access | Times Cited: 41
Recent Advancements in the Atopic Dermatitis Mechanism
Maria Savva, Nikolaos G. Papadopoulos, Stamatios Gregoriou, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 15
Maria Savva, Nikolaos G. Papadopoulos, Stamatios Gregoriou, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 15
A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis
Linda Stein Gold, Robert Bissonnette, Seth Forman, et al.
American Journal of Clinical Dermatology (2025)
Open Access | Times Cited: 1
Linda Stein Gold, Robert Bissonnette, Seth Forman, et al.
American Journal of Clinical Dermatology (2025)
Open Access | Times Cited: 1
Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases
Brian Kim, Marc E. Rothenberg, Xin Sun, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 4, pp. 879-893
Open Access | Times Cited: 30
Brian Kim, Marc E. Rothenberg, Xin Sun, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 4, pp. 879-893
Open Access | Times Cited: 30
The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials
Sanghyuk Yoon, Kihun Kim, Kihyuk Shin, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 52-61
Closed Access | Times Cited: 29
Sanghyuk Yoon, Kihun Kim, Kihyuk Shin, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 52-61
Closed Access | Times Cited: 29
Upadacitinib: Mechanism of action, clinical, and translational science
Mohamed‐Eslam F. Mohamed, Sumit Bhatnagar, Julie Parmentier, et al.
Clinical and Translational Science (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 28
Mohamed‐Eslam F. Mohamed, Sumit Bhatnagar, Julie Parmentier, et al.
Clinical and Translational Science (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 28
Challenges and Future Trends in Atopic Dermatitis
Julius Garcia Gatmaitan, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11380-11380
Open Access | Times Cited: 23
Julius Garcia Gatmaitan, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11380-11380
Open Access | Times Cited: 23
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
Real‐world effectiveness of abrocitinib treatment in patients with difficult‐to‐treat atopic dermatitis
Jill I. Olydam, Anne R. Schlösser, Paolo Custurone, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 12, pp. 2537-2542
Open Access | Times Cited: 15
Jill I. Olydam, Anne R. Schlösser, Paolo Custurone, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 12, pp. 2537-2542
Open Access | Times Cited: 15
Heat shock protein 90 inhibition attenuates inflammation in models of atopic dermatitis: a novel mechanism of action
Hakim Ben Abdallah, Anne Bregnhøj, Gautam S. Ghatnekar, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Hakim Ben Abdallah, Anne Bregnhøj, Gautam S. Ghatnekar, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis
Shiyun Zhang, Bingjie Zhang, Yuehua Liu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Shiyun Zhang, Bingjie Zhang, Yuehua Liu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6
A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries
Amani AlFalasi, Ahmed Ameen, Atlal Al Lafi, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Amani AlFalasi, Ahmed Ameen, Atlal Al Lafi, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Canthaxanthin ameliorates atopic dermatitis in mice by suppressing Th2 immune response
Shuying Peng, Lu Yu, Ming Jiang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113975-113975
Closed Access
Shuying Peng, Lu Yu, Ming Jiang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113975-113975
Closed Access
Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
Ga Hee Jeong, Ki-Chan Kim, Ji Hyun Lee
Cells (2025) Vol. 14, Iss. 2, pp. 83-83
Open Access
Ga Hee Jeong, Ki-Chan Kim, Ji Hyun Lee
Cells (2025) Vol. 14, Iss. 2, pp. 83-83
Open Access
The evolving therapeutic landscape in atopic dermatitis
Luis Angel Hernández-Zárate, Carlos Andrés Gómez-Núñez, Stefan Narváez-Labuhn, et al.
(2025) Vol. 3
Closed Access
Luis Angel Hernández-Zárate, Carlos Andrés Gómez-Núñez, Stefan Narváez-Labuhn, et al.
(2025) Vol. 3
Closed Access
Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
Stamatios Gregoriou, Ioannis‐Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Dermatology and Therapy (2025)
Open Access
Stamatios Gregoriou, Ioannis‐Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Dermatology and Therapy (2025)
Open Access
κ-Carrageenan tetrasaccharide ameliorates particulate matter-induced defects in skin hydration of human keratinocytes cells and skin barrier disorders
Chun‐Hua Zhu, Tao Hong, Hebin Li, et al.
International Journal of Biological Macromolecules (2025), pp. 140395-140395
Closed Access
Chun‐Hua Zhu, Tao Hong, Hebin Li, et al.
International Journal of Biological Macromolecules (2025), pp. 140395-140395
Closed Access
Successful treatment of concurrent atopic dermatitis and psoriatic arthritis with upadacitinib
Gianluca Tavoletti, Giovanni Lasagni, Valeria Fabbri, et al.
Italian Journal of Dermatology and Venereology (2025) Vol. 159, Iss. 6
Closed Access
Gianluca Tavoletti, Giovanni Lasagni, Valeria Fabbri, et al.
Italian Journal of Dermatology and Venereology (2025) Vol. 159, Iss. 6
Closed Access
The role of natural products targeting macrophage polarization in sepsis-induced lung injury
Yake Li, Sinan Ai, Yuan Li, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Yake Li, Sinan Ai, Yuan Li, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Unveiling prognostic value of JAK/STAT signaling pathway related genes in colorectal cancer: a study of Mendelian randomization analysis
Nan Zhang, Wenli Yue, Bo Jiao, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
Nan Zhang, Wenli Yue, Bo Jiao, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
Network pharmacology integrated with experimental validation reveals the mechanism of Xanthii Fructus against allergic rhinitis via JAK2/STAT3/HIF-1α signaling pathway
Jinrui Xiong, Yu Xiong Wu, Liuling Luo, et al.
Journal of Ethnopharmacology (2025), pp. 119461-119461
Closed Access
Jinrui Xiong, Yu Xiong Wu, Liuling Luo, et al.
Journal of Ethnopharmacology (2025), pp. 119461-119461
Closed Access
Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
